ALNY vs ANF · P/E 76, rev $1.29B vs P/E 8.6, rev $2.38B
Alnylam Pharmaceuticals Inc (ALNY) versus Abercrombie & Fitch Company (ANF) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Abercrombie & Fitch Company (ANF) is a apparel retail company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ANF revenue for 2026-08-01 was $2.38B. Net income was $250.9M. ANF currently screens at market cap $4.15B and trailing P/E 8.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ANF currently screens at market cap $4.15B and trailing P/E 8.6.
Not investment advice. Open the ALNY and ANF stock pages for the full models.
Not investment advice.